Helsana HealthInvest

Helsana HealthInvest is the corporate venture arm of Helsana, Switzerland’s largest health insurer, deploying capital strategically into digital health companies that align with the insurer’s Swiss and broader European member base. The fund is balance-sheet capital rather than a traditional limited-partnership vehicle, which means investment pacing is opportunistic and tied to Helsana’s strategic priorities in prevention, chronic disease management, telemedicine, and member engagement. Check sizes are not publicly disclosed but plausibly fall in the CHF 1M to CHF 5M range for early growth rounds, often as a strategic minority alongside a financial lead. Healthcare exposure is total, and AI is welcome where it supports member-facing services or actuarial use cases. Geographic preference skews to Switzerland, the DACH region, and pan-European companies that can plug into Helsana’s distribution. Founders best suited are post-revenue digital health CEOs who can articulate a concrete pilot or commercial path with a Swiss insurer, particularly in behavioral health, musculoskeletal care, women’s health, or remote monitoring. Founders who do not fit include US-only companies, biotech, devices without an insurance reimbursement story, and pre-revenue teams without a clear payer use case. The entry path is warm introduction through a Helsana executive, a Swiss digital health operator, or a portfolio CEO. LinkedIn outreach to the HealthInvest team with a focused one-page Switzerland market entry plan is a credible second option. Expect strategic questions about integration, data, and member outcomes alongside standard financial diligence.